Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02050919
What this trial is testing

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Who this might be right for
Pleomorphic RhabdomyosarcomaStage IIB Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7+1 more
OHSU Knight Cancer Institute 20
Early research (Phase 1)Study completedNCT00288431
What this trial is testing

Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)

Who this might be right for
CancerSarcoma
Merck Sharp & Dohme LLC 37
Testing effectiveness (Phase 2)Study completedNCT00002131
What this trial is testing

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Otsuka America Pharmaceutical 28
Large-scale testing (Phase 3)Study completedNCT00002445
What this trial is testing

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Who this might be right for
Sarcoma, KaposiHIV Infections
Cytran 200
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Early research (Phase 1)Study completedNCT01016730
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00002995
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 483
Early research (Phase 1)UnknownNCT01242072
What this trial is testing

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Who this might be right for
MalignancyCancerNon Small Cell Lung Cancer+5 more
Alaunos Therapeutics 12
Large-scale testing (Phase 3)WithdrawnNCT00334867
What this trial is testing

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00881595
What this trial is testing

Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcomas
University of Florida
Testing effectiveness (Phase 2)Looking for participantsNCT06367075
What this trial is testing

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft-tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Study completedNCT02487979
What this trial is testing

Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma

Who this might be right for
Recurrent Osteosarcoma
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Early research (Phase 1)Looking for participantsNCT07121946
What this trial is testing

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more
LTZ Therapeutics, Inc. 42
Testing effectiveness (Phase 2)UnknownNCT02812654
What this trial is testing

Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment

Who this might be right for
Sarcoma, Soft Tissue
AC Camargo Cancer Center 70
Early research (Phase 1)Looking for participantsNCT06830031
What this trial is testing

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more
Shanghai Exuma Biotechnology Ltd. 18
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)UnknownNCT01552239
What this trial is testing

Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-margins

Who this might be right for
Soft Tissue Sarcoma of the LimbAJCC Stage II and III
Technical University of Munich 50
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Next Page